These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18583784)

  • 1. Use of anti-retrovirals in pediatric HIV infection.
    Gaur S
    Indian J Dermatol Venereol Leprol; 2008; 74(3):208-14. PubMed ID: 18583784
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of antiretroviral therapy in neonates, children, and adolescents.
    Neely M; Kovacs A
    Curr HIV/AIDS Rep; 2004 Jun; 1(2):97-104. PubMed ID: 16091229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
    de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
    Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.
    Adjé-Touré C; Hanson DL; Talla-Nzussouo N; Borget MY; Kouadio LY; Tossou O; Fassinou P; Bissagnene E; Kadio A; Nolan ML; Nkengasong JN
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):911-7. PubMed ID: 18593341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective drug taking during combination antiretroviral therapy.
    Lanzafame M; Melotti R; Lattuada E; Boccafoglio F; Concia E; Verlato G; Vento S
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):490-1. PubMed ID: 17353720
    [No Abstract]   [Full Text] [Related]  

  • 8. A case for reduced frequency of CD4 count monitoring for children on combination antiretroviral therapy with consistently undetectable HIV viral load.
    Johnson SM; Standing JF; Klein N; Irwin AD; Shingadia D; Lonsdale DO; Gilmour KC; Flynn J; Manns C; Clapson M; Bamford A
    HIV Med; 2019 Apr; 20(4):e8-e9. PubMed ID: 30693658
    [No Abstract]   [Full Text] [Related]  

  • 9. Issues in antiretroviral therapy: when to start?
    Boyle BA
    AIDS Read; 2001 Feb; 11(2):66-70. PubMed ID: 11279874
    [No Abstract]   [Full Text] [Related]  

  • 10. Viral Suppression in a Nationwide Sample of HIV-Infected Children on Antiretroviral Therapy in Rwanda.
    Nsanzimana S; McArdle F; Remera E; Mulindabigwi A; Ribakare M; Ndimubanzi P; Kayirangwa E; Baribwira C; Riedel DJ; Ntaganira J
    Pediatr Infect Dis J; 2019 Feb; 38(2):149-151. PubMed ID: 29794653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy 2002: old and new paradigms.
    Sherer R
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(4):121-30. PubMed ID: 12942670
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
    Krogstad PA
    J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
    [No Abstract]   [Full Text] [Related]  

  • 13. Approaches to interrupting HAART for the treatment of HIV infection. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    Dybul M;
    IAPAC Mon; 2001 Aug; 7(8):232-4. PubMed ID: 11708275
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicities of antiretroviral therapy in children.
    Nwaobasi E; Oleske JM
    AIDS Read; 2006 Oct; 16(10):537-40, 544-6,549-50, 552-4. PubMed ID: 17096472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
    Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
    AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating HIV antiretroviral therapy: criteria, evidence, and controversy.
    Maldonado A
    JAAPA; 2011 Feb; 24(2):26-30. PubMed ID: 21387967
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on antiretroviral therapy.
    Riordan A; Bugembe T
    Arch Dis Child; 2009 Jan; 94(1):70-4. PubMed ID: 18838416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of mother-to-child transmission.
    Surjushe A; Maniar J
    Indian J Dermatol Venereol Leprol; 2008; 74(3):200-7. PubMed ID: 18583783
    [No Abstract]   [Full Text] [Related]  

  • 20. Updated European paediatric guidelines focus on long-term health consequences of HIV-1 infection and treatment.
    Tobin SC
    AIDS; 2015 Jun; 29(10):N5. PubMed ID: 26035330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.